Concepedia

Publication | Closed Access

99O_PR KRYSTAL-1: Activity and preliminary pharmacodynamic (PD) analysis of adagrasib (MRTX849) in patients (Pts) with advanced non–small cell lung cancer (NSCLC) harboring KRASG12C mutation

DOI

80

Citations

0

References

2021

Year

G.J. Riely, S-H.I. Ou, Igor I. Rybkin, Alexander I. Spira, K. Papadopoulos, Joshua K. Sabari, Melissa L. Johnson, Rebecca S. Heist, Lyudmila Bazhenova, Minal Barve,
Journal of Thoracic Oncology

No additional data available for this publication yet. Check back later!